Poland· PL-100422962

Frimig

A sumatriptan product containing sumatriptanum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.

ATC N02CC01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFrimigATCN02CC01REGISTER NO.PL-100422962PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Sumatriptan is registered in 17 of 19 countries.

Countries holding a registration under ATC N02CC01 (sumatriptan), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Sumatriptan · ATC N02CC01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sumatriptan costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.13 in United States to $2.70 in Switzerland — a ×21 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Sumatriptan · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.70
  • IT Italy$0.71
  • FR France$0.59
  • US United States$0.13 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Sumatriptanum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
N02CC01
ATC class
Sumatriptan
Defined daily dose
20 mg, N
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909991409203
  • gtin
    05909991409210
  • gtin
    05909991409234
  • gtin
    05909991409128
  • gtin
    05909991409180
  • gtin
    05909991409197

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

147 interactions on record for sumatriptan.

Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sumatriptan · interactions on record

147 records

  • 13 severe
  • 4 moderate
  • 129 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sumatriptan in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sumatriptan products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Amigro, Imigran
  • Belgium · Imitrex, Imitrex Instant
  • Bulgaria · Амигрен, Имигран
  • Cyprus · Imigran
  • Czechia · Frimig, Frimig Neo
  • Germany · Imigran, Imigran Mite
  • Denmark · Damigra, Imigran
  • Estonia · Cinie, Imigran Fdt
  • Spain · Imigran, Imigran Neo
  • Finland · Damigra, Imigran
  • France · Imigrane, Imiject
  • United Kingdom (Northern Ireland) · Almus Sumatriptan, Boots Migraine Relief
  • Greece · Forcet, Hedimal
  • Croatia · Imigran, Sumigra
  • Hungary · Cinie, Frimig
  • Ireland · Imigran, Imigran Ftab
  • Iceland · Damigra, Imigran
  • Italy · Imigran, Sumatriptan Accord
  • Lithuania · Cinie, Imigran
  • Luxembourg · Imitrex, Imitrex Instant
  • Latvia · Cinie
  • Malta · Imigran, Sumatriptan Aurobindo
  • Netherlands · Damigra, Imigran
  • Norway · Damigra, Imigran
  • Portugal · Imigran
  • Romania · Imigran Dr, Sumacta
  • Sweden · Damigra, Imigran
  • Slovenia · Imigran, Imigran Sprint
  • Slovakia · Cinie, Imigran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0caf23b2-e1c7-4939-9ccb-3e767e55b1a0
GET /v1/drugs/0caf23b2-e1c7-4939-9ccb-3e767e55b1a0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991409128 ¦ Rp ¦ 133364\n2 tabl.\n05909991409180 ¦ Rp ¦ 133370\n3 tabl.\n05909991409197 ¦ Rp ¦ 133371\n4 tabl.\n05909991409203 ¦ Rp ¦ 133372\n6 tabl.\n05909991409210 ¦ Rp ¦ 133373\n12 tabl.\n05909991409234 ¦ Rp ¦ 133375\n18 tabl.",
  "substance": "Sumatriptanum 50 mg",
  "common_name": "Sumatriptanum",
  "pl_product_id": "100422962",
  "pozwolenie_nr": "251/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-07-05"
}

See everything about sumatriptan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.